Search results
Results From The WOW.Com Content Network
The shortage means people like Amanda Cella, a 37-year-old South Jersey resident, have to scramble to find a pharmacy that still has the drug in stock. Cella was prescribed Zepbound in February.
April 17, 2024 at 1:51 PM. (Reuters) -Most doses of Eli Lilly's diabetes drug Mounjaro and weight-loss drug Zepbound would be in limited supply through the second quarter of this year due to ...
Eli Lilly reports $2 billion from Mounjaro, Zepbound in Q1 2024. Anjalee Khemlani. April 30, 2024 at 1:23 PM ... Eli Lilly said it is also increasing access to the weight-loss drug Zepbound ...
Prescriptions for Zepbound, which was approved by the U.S. Food and Drug Administration on Nov. 8, can be filled at retail and mail-order pharmacies as of Dec. 5, drug maker Eli Lilly announced.
The Food and Drug Administration on Wednesday approved Zepbound, a new weight loss drug from drugmaker Eli Lilly that was shown in clinical trials to help people lose up to 52 pounds in 16 months ...
The U.S. Food and Drug Administration approved Zepbound, a new weight loss drug from pharmaceutical company Eli Lilly, on Wednesday. Zepbound is a once-weekly injectable medication with an active ...
The Food and Drug Administration approved Zepbound for use by adults with a body mass index, or BMI, of at least 30 or a BMI of 27 or more if a patient also has another weight-related condition ...
Rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro, pushed Eli Lilly to a better-than-expected first-quarter profit. The drugmaker also hiked its ...